Rethinking Obesity

Giles presents a groundbreaking perspective on obesity, labeling it as a chronic brain condition rather than a simple issue of willpower. He highlights the potential of new drugs like Ozempic and Wegovy, which target gut hormones to communicate fullness to the brain more effectively. This shift in understanding could revolutionize how obesity is treated, emphasizing the importance of addressing the brain's role in eating behaviors.